Variant report
Variant | nsv874123 |
---|---|
Chromosome Location | chr2:52706489-52730021 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:32)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:32 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr2:52706340-52706490 | AG04450 | lung: | n/a | n/a |
2 | CTCF | chr2:52706560-52706710 | HEEpiC | esophagus: | n/a | n/a |
3 | CTCF | chr2:52706340-52706490 | HEEpiC | esophagus: | n/a | n/a |
4 | E2F4 | chr2:52726538-52726745 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | E2F4 | chr2:52716051-52716210 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | EP300 | chr2:52725664-52725727 | GM12878 | blood: | n/a | n/a |
7 | GATA3 | chr2:52719241-52719532 | SH-SY5Y | brain: | n/a | n/a |
8 | IRF3 | chr2:52713294-52713305 | GM12878 | blood: | n/a | n/a |
9 | JUN | chr2:52722986-52723289 | K562 | blood: | n/a | n/a |
10 | JUN | chr2:52721276-52721322 | HepG2 | liver: | n/a | n/a |
11 | MAFF | chr2:52721437-52721549 | HepG2 | liver: | n/a | n/a |
12 | MAFK | chr2:52713147-52713257 | IMR90 | lung: | n/a | chr2:52713158-52713169 chr2:52713153-52713169 chr2:52713157-52713168 chr2:52713158-52713169 chr2:52713153-52713168 |
13 | MAFK | chr2:52721404-52721556 | HepG2 | liver: | n/a | n/a |
14 | MAFK | chr2:52721401-52721622 | HepG2 | liver: | n/a | n/a |
15 | MAFK | chr2:52713114-52713271 | HepG2 | liver: | n/a | chr2:52713158-52713169 chr2:52713153-52713169 chr2:52713157-52713168 chr2:52713158-52713169 chr2:52713153-52713168 |
16 | MAFK | chr2:52713039-52713209 | HepG2 | liver: | n/a | chr2:52713158-52713169 chr2:52713153-52713169 chr2:52713157-52713168 chr2:52713158-52713169 chr2:52713153-52713168 |
17 | MAFK | chr2:52707497-52707683 | HepG2 | liver: | n/a | n/a |
18 | POLR2A | chr2:52707308-52707474 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | POLR2A | chr2:52707015-52707034 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr2:52720346-52720500 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | RAD21 | chr2:52706242-52706552 | H1-hESC | embryonic stem cell: | n/a | n/a |
22 | SPI1 | chr2:52725541-52725858 | GM12878 | blood: | n/a | n/a |
23 | SPI1 | chr2:52725544-52725776 | GM12891 | blood: | n/a | n/a |
24 | SPI1 | chr2:52725514-52725796 | GM12891 | blood: | n/a | n/a |
25 | SPI1 | chr2:52706565-52706786 | HL-60 | blood: | n/a | n/a |
26 | STAT3 | chr2:52723592-52723863 | MCF10A-Er-Src | breast: | n/a | chr2:52723770-52723777 |
27 | STAT3 | chr2:52708548-52708556 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | STAT3 | chr2:52710658-52710858 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | STAT3 | chr2:52727658-52727810 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | STAT3 | chr2:52707741-52707863 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | STAT3 | chr2:52714125-52714316 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | TEAD4 | chr2:52706142-52706582 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ASB3-3 | chr2:52722903-52722974 | XLOC_002095 |
2 | lnc-ASB3-3 | chr2:52721826-52722000 | XLOC_002095 |
3 | lnc-ASB3-3 | chr2:52727682-52727890 | XLOC_002095 |
4 | lnc-ASB3-3 | chr2:52725741-52725923 | XLOC_002095 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000225842 | TF binding region |
ENSG00000236837 | TF binding region |
RABEP1 | miRNA target sites |
RAD23B | miRNA target sites |
RAB9B | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13407104 | chr2:52706489-52706490 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs369055629 | chr2:52706494-52706495 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs373487791 | chr2:52706498-52706499 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs548140973 | chr2:52706542-52706543 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs6760658 | chr2:52721889-52721890 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs183134793 | chr2:52721891-52721892 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs373846948 | chr2:52721898-52721899 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs548303190 | chr2:52721926-52721927 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs187124321 | chr2:52721936-52721937 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs570235571 | chr2:52721991-52721992 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs528365748 | chr2:52722806-52722807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548326664 | chr2:52722815-52722816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs116495765 | chr2:52722817-52722818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141406683 | chr2:52722833-52722834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4971836 | chr2:52722835-52722836 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs145282772 | chr2:52722849-52722850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185616967 | chr2:52722864-52722865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs72892924 | chr2:52722885-52722886 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs368269216 | chr2:52722886-52722887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146421197 | chr2:52722894-52722895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571222732 | chr2:52722898-52722899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536113717 | chr2:52722902-52722903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552900930 | chr2:52722922-52722923 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs574440522 | chr2:52722932-52722933 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs527392277 | chr2:52722934-52722935 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs548989745 | chr2:52722971-52722972 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs17043033 | chr2:52722976-52722977 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs190487733 | chr2:52722981-52722982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs117953477 | chr2:52722988-52722989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375246615 | chr2:52722996-52722997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs72892927 | chr2:52723020-52723021 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs114628095 | chr2:52723026-52723027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4971606 | chr2:52723031-52723032 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs542078364 | chr2:52723068-52723069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561939286 | chr2:52723109-52723110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140955476 | chr2:52723112-52723113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544188847 | chr2:52723128-52723129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570963693 | chr2:52723147-52723148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368789731 | chr2:52723155-52723156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs538418837 | chr2:52723163-52723164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150415195 | chr2:52723198-52723199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs193118588 | chr2:52723232-52723233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546896284 | chr2:52723320-52723321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567029438 | chr2:52723321-52723322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs150115265 | chr2:52723334-52723335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs572403043 | chr2:52723351-52723352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138421506 | chr2:52723367-52723368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184488168 | chr2:52723373-52723374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs17733177 | chr2:52723375-52723376 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs76008555 | chr2:52723385-52723386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:52722800-52723800 | Enhancers | Liver | Liver |
2 | chr2:52723800-52724600 | Weak transcription | Liver | Liver |
3 | chr2:52724600-52725800 | ZNF genes & repeats | Liver | Liver |
4 | chr2:52725800-52727200 | Weak transcription | Liver | Liver |
5 | chr2:52727200-52730600 | Enhancers | Liver | Liver |
6 | chr2:52727400-52729600 | Enhancers | Fetal Heart | heart |
7 | chr2:52727600-52728600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
8 | chr2:52727600-52729800 | Enhancers | Fetal Lung | lung |
9 | chr2:52727800-52728000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
10 | chr2:52728000-52728600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
11 | chr2:52728600-52729400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
12 | chr2:52728800-52729600 | Enhancers | Fetal Intestine Small | intestine |
13 | chr2:52728800-52729600 | Enhancers | Left Ventricle | heart |
14 | chr2:52728800-52729600 | Enhancers | Pancreas | Pancrea |
15 | chr2:52728800-52730400 | Enhancers | Fetal Intestine Large | intestine |